Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 22022424)

1.

The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression.

Bie L, Zhao G, Cheng P, Rondeau G, Porwollik S, Ju Y, Xia XQ, McClelland M.

PLoS One. 2011;6(10):e25631. doi: 10.1371/journal.pone.0025631. Epub 2011 Oct 12.

2.

Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.

Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K, Gabrielson E.

Clin Cancer Res. 2006 Jan 15;12(2):405-10.

3.

Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.

Xu Y, Yuan J, Zhang Z, Lin L, Xu S.

Mol Biol Rep. 2012 Sep;39(9):8979-85. doi: 10.1007/s11033-012-1767-9. Epub 2012 Jun 20.

PMID:
22714920
5.

Identification of expressed genes characterizing long-term survival in malignant glioma patients.

Yamanaka R, Arao T, Yajima N, Tsuchiya N, Homma J, Tanaka R, Sano M, Oide A, Sekijima M, Nishio K.

Oncogene. 2006 Sep 28;25(44):5994-6002. Epub 2006 May 1.

PMID:
16652150
6.

Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.

Grabsch H, Takeno S, Parsons WJ, Pomjanski N, Boecking A, Gabbert HE, Mueller W.

J Pathol. 2003 May;200(1):16-22.

PMID:
12692836
7.

Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.

Marucci G, Morandi L, Magrini E, Farnedi A, Franceschi E, Miglio R, Calò D, Pession A, Foschini MP, Eusebi V.

Virchows Arch. 2008 Dec;453(6):599-609. doi: 10.1007/s00428-008-0685-7. Epub 2008 Oct 25.

PMID:
18953566
8.

Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients.

Wager M, Guilhot J, Blanc JL, Ferrand S, Milin S, Bataille B, Lapierre F, Denis S, Chantereau T, Larsen CJ, Karayan-Tapon L.

Br J Cancer. 2006 Oct 23;95(8):1062-9.

9.

Differential expression of centrosomal proteins at different stages of human glioma.

Loh JK, Lieu AS, Chou CH, Lin FY, Wu CH, Howng SL, Chio CC, Hong YR.

BMC Cancer. 2010 Jun 9;10:268. doi: 10.1186/1471-2407-10-268.

10.

Increased expression of FAT10 is correlated with progression and prognosis of human glioma.

Yuan J, Tu Y, Mao X, He S, Wang L, Fu G, Zong J, Zhang Y.

Pathol Oncol Res. 2012 Oct;18(4):833-9. Epub 2012 Mar 9.

PMID:
22402871
11.

Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.

Bao ZS, Li MY, Wang JY, Zhang CB, Wang HJ, Yan W, Liu YW, Zhang W, Chen L, Jiang T.

CNS Neurosci Ther. 2014 Feb;20(2):112-8. doi: 10.1111/cns.12171. Epub 2013 Nov 27.

PMID:
24279471
12.

Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.

Carlsson E, Krohn K, Ovaska K, Lindberg P, Häyry V, Maliniemi P, Lintulahti A, Korja M, Kivisaari R, Hussein S, Sarna S, Niiranen K, Hautaniemi S, Haapasalo H, Ranki A.

Genes Chromosomes Cancer. 2013 Feb;52(2):191-201. doi: 10.1002/gcc.22019. Epub 2012 Oct 25.

PMID:
23097141
13.

Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.

Ko YH, Roh JH, Son YI, Chung MK, Jang JY, Byun H, Baek CH, Jeong HS.

J Oral Pathol Med. 2010 Apr;39(4):349-55. doi: 10.1111/j.1600-0714.2009.00835.x. Epub 2009 Dec 16.

PMID:
20040022
15.

Gene expression profile as a prognostic factor in high-grade gliomas.

Czernicki T, Zegarska J, Paczek L, Cukrowska B, Grajkowska W, Zajaczkowska A, Brudzewski K, Ulaczyk J, Marchel A.

Int J Oncol. 2007 Jan;30(1):55-64.

PMID:
17143512
16.

Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma.

D'Urso PI, D'Urso OF, Storelli C, Catapano G, Gianfreda CD, Montinaro A, Muscella A, Marsigliante S.

J Neurooncol. 2011 Aug;104(1):113-8. doi: 10.1007/s11060-010-0481-5. Epub 2010 Dec 3.

PMID:
21127944
17.

Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.

Cheng MW, Wang BC, Weng ZQ, Zhu XW.

Acta Histochem. 2012 Sep;114(5):503-9. doi: 10.1016/j.acthis.2011.09.004. Epub 2011 Oct 13.

PMID:
22000864
18.

Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.

Fujita A, Yamamoto H, Imamura M, Nakamura N, Maehara Y, Tsuneyoshi M, Oda Y.

Virchows Arch. 2012 Feb;460(2):163-9. doi: 10.1007/s00428-011-1181-z. Epub 2011 Dec 22.

PMID:
22190007
19.

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

Gorovets D, Kannan K, Shen R, Kastenhuber ER, Islamdoust N, Campos C, Pentsova E, Heguy A, Jhanwar SC, Mellinghoff IK, Chan TA, Huse JT.

Clin Cancer Res. 2012 May 1;18(9):2490-501. doi: 10.1158/1078-0432.CCR-11-2977. Epub 2012 Mar 13.

20.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.

Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S.

Mod Pathol. 2007 Jan;20(1):76-83. Epub 2006 Sep 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk